
News • Drug safety research
Under the influence: Which medicines affect driving most?
A more comprehensive system for drug safety evaluation: Researchers have developed a new tool to estimate the risk of using medicines while driving.

A more comprehensive system for drug safety evaluation: Researchers have developed a new tool to estimate the risk of using medicines while driving.

Researchers have developed a novel 3D‑printed ceramic implant material that closely mimics real human bone. The findings may lead to more effective and accessible treatments for bone defects.

Changes in gut microbiota after bariatric surgery are strongly linked to altered metabolic health and sustained improvement in type 2 diabetes, according to a new study.

A CRISPR-based tool called Cas12a2 can selectively eliminate cancer and virus-infected cells based on their RNA signature – with high precision and no off-target effects.

Now, a new study identified a gene therapy for individuals with cystic fibrosis (CF) caused by a specific mutation and for whom there was no treatment available until now.

Total hip replacement performed with robotic techniques has a lower reoperation rate than the conventional procedure, according to a six-year study.

Why does the same genetic mutation cause FCDII in some patients but not in others? Researchers developed organoids to model a brain malformation responsible for drug-resistant epilepsy in children.

New research reveals that extracellular vesicles derived from menstrual blood stromal cells can improve cartilage repair, suggesting an innovative cell-free therapy for osteoarthritis.

Researchers conducted the first randomized trial of transesophageal echocardiography (TEE)-guided CPR, showing improved blood flow indicators during resuscitation of cardiac arrest patients.

Researchers have developed a new MRI-based method that enables objective quantification of the growth of the most aggressive brain tumours, particularly glioblastoma.

A biomarker discovered in the cerebrospinal fluid could improve diagnosis of Parkinson's disease and dementia with Lewy bodies.

At this year’s European Congress of Radiology (ECR) in Vienna, Bayer presented new data on a contrast agent that could transform MRI imaging: gadoquatrane, which requires up to 60% less gadolinium than previous standard macrocyclic preparations whilst maintaining the same diagnostic accuracy. Prof. Hubertus Pietsch, Head of MRI & CT Contrast Agent Research at Bayer and one of the key…

Diagnostic imaging without actual images, but with sleek and shiny scanners; no more radiology and pathology departments, but virtual patient models and AI-enhanced surgical precision: At this year's European Congress of Radiology (ECR) in Vienna, two leading experts envisioned 2050 as a radically different future of medicine – less Grey's Anatomy, more Star Trek. They made it clear…

Psychiatrists and neuroimaging experts gathered to explore one of the last remaining frontiers in radiology – the human mind – at the annual meeting of the French Society of Radiology (JFR) last October in Paris. Their conversation oscillated between neurons and narratives, algorithms and emotions – a vivid reminder that psychiatry is not only about understanding the brain, but about…

Functional brain radiosurgery is an application of stereotactic radiosurgery (SRS), representing its newest clinical field. It is a precise, non-invasive medical technique using focused ionising radiation to precisely target specific brain structures to modulate brain function for neurological disorders, psychiatric conditions, or intractable pain. The technology offers “precision without…

Pancreatic cancer remains a diagnostic challenge, due to unspecific early symptoms and lack of effective screening tools. A novel AI metabolomics platform could help overcome these issues.

Type 2 diabetes and high blood pressure share a genetic link, new research from the UK and France shows. People with one condition are more likely to develop the other.

Radiotherapy is more effective when administered at the right time of day, according to new research. This discovery opens the door to cancer “chronotherapy”, the researchers hope.

Advances in artificial intelligence and multimodal data integration are poised to revolutionise cancer diagnostics – but significant challenges remain before these technologies can be routinely deployed in clinical practice. Professor Manuel Salto-Tellez outlined the steps needed to bridge the gap between complex tumour biology and the relatively simple biomarkers currently available, speaking…

Researchers have developed 3D volume rendering methods for cardiac MRI that display complex structures within the heart and show blood flow. This can guide treatment decisions in pediatric patients.

A new kind of intraoperative MRI (iMRI) can perform functional MRI scans in real time during brain surgery — helping surgeons detect potential complications in as little as seven seconds.

Not all cancer mutations are equal: new research shows that a single mutation hotspot can generate a rich diversity of tumour behaviours. This could lead to more personalised cancer treatments.

Rethinking ultrasound gel: To reduce patient discomfort during sonography exams, researchers from Japan propose a natural, reusable solid pad for clearer, more comfortable imaging.

Computational pathology is becoming increasingly important in helping deliver precision medicine to a wider range of patients. Experts at the 37th European Congress of Pathology in Vienna discussed how algorithms can optimise laboratory workflows, generate stronger evidence for molecular tumour boards, and enhance clinical trial design.

Brain fog explained: People with ME/CFS and long Covid experience a disruption to their brain connectivity during a mentally demanding task, new research finds.

Why do some tumours spread while others remain localised? Using colon cancer cells, scientists pinpointed the criteria that influence metastasis risk, and identified a way to assess its probability.

Northwestern University researchers have developed the first device that can continuously track a fetus’s vital signs while still in the uterus — a feat that previously has not been possible.

Non-invasive, millimetre-scale diffusion MRI (dMRI) can be used to detect morphological changes in axons – a common hallmark of a wide range of neurological disorders, new research shows.

Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of genetic diseases. At the 2025 World Medical Innovation Forum in Boston, leading experts explored the possibilities and challenges of these rapidly advancing tools. The case of Baby KJ Muldoon – an infant treated with a personalised CRISPR therapy developed in just seven…

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

To predict the risk of hip fracture, only 7% of the bone mass needs to be analysed, a new study finds. Scientists have identified these critical areas to improving diagnostic methods.

Now, a research team has developed a novel diagnostic approach that enables the rapid and simultaneous detection of both antibiotic resistance and high virulence in Klebsiella pneumoniae.

New research shows that a harmless strain of Klebsiella – discovered by chance in laboratory experiments – can eliminate infections and reduce gut inflammation in inflammatory bowel disease (IBD).

Artificial intelligence is reshaping how clinicians identify women at higher risk of breast cancer – and may soon guide decisions on supplemental screening and treatment. At the European Society of Breast Imaging (EUSOBI) annual scientific meeting in Aberdeen, Scotland, two experts presented their latest findings on AI-driven risk stratification and response prediction.

Even minor functional impairments of the kidneys can have serious consequences for patients after major surgery. New biomarkers could help identify high-risk patients at an early stage.

Researchers have designed a tiny robotic catheter, steered from outside using magnetic fields. The device has the potential to improve infertility treatments, without damaging delicate tissue.

At the 2025 Journées Francophones de Radiologie (JFR), novelist, diplomat, and physician Jean-Christophe Rufin took the stage to remind an audience of radiologists that medicine, at its core, is a human story – one that needs to be told, felt, and shared. Beneath the cold light of MRI scanners and the hum of technology, he reintroduced something fragile yet essential: empathy.

New insights into the intestinal nervous system – or "gut brain" – open new avenues for advancing therapies for allergies, chronic inflammatory bowel diseases and irritable bowel syndrome.

What have been the latest developments in digital R&D and lab automation, patient-centric design, digitalised manufacturing and supply chains? Highlighting the rise of a smart pharma, AUTOMA+ 2025 took place in Vösendorf, Austria on 24-25 November. The event was a dynamic interplay of technology, solutions and forward-thinking ideas.

A European consortium has developed a new decision making framework for health professionals which they hope will transform the care of patients with chronic obstructive pulmonary disease (COPD).

Researchers developed an X-ray imaging method capable of revealing hidden features in a single shot. This could advance cancer detection, disease monitoring, security screening and material analysis.

Depression is not only a disease of the mind or the brain, a new study finds: a research team has revealed deep connections to abnormalities in the body's overall immune response.

Philips and Cortechs.ai have extended their collaboration to integrate AI-enabled quantitative neuroimaging analytics directly into MR systems. The partnership aims to provide radiologists with automated, objective measurements of brain structures and lesions to support diagnosis and monitoring of neurological conditions.

University of Delaware researchers use robotic testing to spot an often overlooked sensory deficit in stroke survivors – proprioception, the body's ability to sense movement and position.

A new solution enables doctors to show 3D images of a patient's anatomy during consultations. The technology is designed to help patients understand their conditions and make informed choices.

In a CT scan of the lungs, accidentally inhaled objects can be extremely subtle and easy to miss, even for experienced clinicians. A new AI model acts as a “second set of eyes” to help detect hidden cases.

New hope for patients with neurological diseases: A combination of focused ultrasound and gene therapy enables targeted, nonsurgical control of seizure-relevant brain regions.

Researchers explore how ultrasound waves can be used to activate chemotherapy drugs only in targeted areas, offering a new path toward safer, more effective cancer treatment.

In the future, health monitors and medical devices could be powered by the body’s natural sugars: A new research project aims to harness power from glucose for implantable medical devices.

Not all PCOS is the same: Researchers identified four subgroups with distinct symptoms and different responses to treatment – opening the door to precision medicine for millions of women worldwide.

3D + time: a new 4D ultrasound imaging technique could both improve our understanding of the circulatory system and facilitate the diagnosis of certain blood circulation-related diseases.

Biomarker testing is ushering in a novel era of therapy personalisation for gastroesophageal and colorectal cancers, according to experts presenting at the 37th European Congress of Pathology in Vienna this September. During a session on state-of-the-art in gastrointestinal biomarkers, speakers outlined how targeted therapies and immunotherapies are transforming treatment options – but…

At the 38th European Association of Nuclear Medicine (EANM) Congress, held from October 4–8 in Barcelona, United Imaging, a global manufacturer of cutting-edge medical imaging technology, showcases its most advanced AI-powered molecular imaging innovations, the uMI Panvivo family and the uMI Panorama family, and highlights the company’s strong growth and confidence in the European market.

A new approach to PET imaging offers a promising way for physicians to promptly identify patients who are at risk for poor functional recovery after a heart attack, according to new research.

An international team has developed an AI model that brings together medical imaging data and clinical information to calculate the risk of breast cancer tumour recurrence more accurately.

Newly discovered blood biomarkers may offer new options to track Duchenne muscular dystrophy (DMD) in a less invasive way than physical tests or biopsies. This could support more tailored treatments.

To help repair soft tissue injuries of the gastrointestinal tract like ulcers or hemorrhages, EPFL researchers envision a new class of device: a pill-sized, swallowable bioprinter.

Traditional diagnostic methods for epilepsy face significant limitations. A new clinical trial explores the potential of advanced brain monitoring to improve diagnosis and management of the condition.

Researchers identified a targeted way to protect the brain from harmful side effects of cranial radiation therapy, potentially preserving the quality of life for millions of brain cancer survivors.

In the NICU, a few hours can mean the difference between unnecessary procedures and targeted, life-saving treatment. A new speed record for WGS opens new diagnostic possibilities.

A novel imaging solution, called PSMA PET scanning, can more effectively detect the recurrence of prostate cancer compared to standard methods, and is associated with improved survival outcomes.

An expert summit for craniomaxillofacial (CMF) care brought together leading surgeons to explore how digital technologies are reshaping surgical planning, precision, and patient outcomes.

Cardiac imaging is evolving, and new techniques continue to uncover the secrets of the heart for cardiologists who know how to use them. At the ESC 2025 Congress in Madrid, four experts explored cutting-edge developments across different modalities. Ranging from AI-assisted ultrasound image acquisition and accelerated MRI protocols to advanced prognostic tools for CT and nuclear imaging, these…

Breast cancer claims around 670.000 lives each year. Now, researchers propose that whole genome sequencing (WGS) could help many patients find better treatments or match them with clinical trials.

Precision Oncology Ireland (POI), a €28M cancer research programme uniting universities, charities and industry to develop tailored diagnostic and therapeutic solutions, has now entered phase 2.

The heterogeneity of critical illnesses like sepsis, ARDS, and trauma creates immense challenges. A new, unified way to classify patients aims to improve treatment.

Asking people how much money they would accept to experience pain again can provide a more accurate and comparable measure of pain levels than the familiar 1–10 scale, according to new research.

Hospitalists frequently discuss the risks associated with tests, treatments, and/or surgical procedures with their patients. But is everyone in the clear on what a “slight risk of complications” actually means? A session on the meaning of risk to patients and how to effectively communicate risk was discussed at SHM Converge 2025, the annual meeting of the Society of Hospitalist Medicine.

University of Stuttgart scientists develop enhanced CRISPR technique that makes genetic loss-of-function analyses more efficient and reproducible for medical research.

To tackle the shortage of donor organs, researchers have developed a 3D printer that doesn’t just print implantable tissues, it also sees and even co-designs parts of organs.

A novel procedure at UC San Diego Health uses a combination of artificial intelligence and 3D printing to develop a customized implant for the spine during fusion surgery.

A newly developed method to accurately quantify how much radiation is absorbed by the blood during cancer treatment could lead to more personalised, preventive, and safer radiotherapy.

Scientists developed an AI-based approach to diagnose colorectal cancer from different microbial subgroups in the gut microbiota – a non-invasive and low-cost alternative to colonoscopy screening.

Tracer molecules serve to provide visual guidance in nuclear medicine, but a new molecule could give surgeons additional audio cues to help them locate prostate cancer tumors and metastases.

Henkjan Huisman has been appointed Professor of AI Guided Imaging at Radboud UMC/Radboud University. With a focus on AI applications in medical imaging, his goal is to provide better and more affordable care.

Remote monitoring via microfluidic platforms, AI-assisted sensor systems, and more: Attendees of the Labmed Forum at Medica saw impressive examples on how wearable technology is becoming a transformative force in laboratory medicine to improve real-time monitoring of patients, covering widespread conditions such as diabetes, asthma and COPD. With an emphasis on remote monitoring, devices are…

The vaginal microbiome is a largely overlooked area of medicine that could dramatically improve outcomes for common infections, infertility and even cancer for millions of women, a new review finds.

Microsatellite instability-high (MSI-H) tumors are associated with better clinical outcomes. A novel AI model for accurate MSI prediction could help battle gastric and colorectal cancers.

Microrobots formed in droplets could enable precision-targeted drug delivery, improving on IV drug delivery that sends only 0.7% of the drug to the target tissue, according to a recent study.

Dense calcifications are common in breast tissue, but not every finding in a mammogram is a precursor of cancer. New insights could lead to fewer benign biopsies and guide therapeutic development.

By identifying the unique biological signatures that guide AI tissue classification, new research lays the foundation for smart surgical tools with the added feature of biomolecular-level precision.

At Medical Taiwan 2025, manufacturers attracted attendees with a wide range of innovations. We took a closer look at some of the most exciting companies and their products on display at the medical, health and care expo.

Korean researchers have developed a wireless implantable drug delivery system that enable chemotherapy drugs to penetrate deep into solid tumors—without harming surrounding healthy tissue.

Medical Taiwan has long been a showcase for cutting-edge healthcare solutions, but this year marked a pivotal moment. Visitors of the latest edition of the medical, health and care expo in Taipei witnessed a particularly noticeable step forward: the definitive transition of medical AI from promising research to actual clinical practice. Organized by the Taiwan External Trade Development Council…

A new technique called photoacoustic computed tomography (PACT) offers a breast imaging alternative without the discomfort, high costs, or risk associated with the conventional evaluation methods.

Molecular markers in saliva could reveal the risk of a person developing major diseases such as cancer, cardiovascular diseases, diabetes and neurodegenerative diseases, new research finds.

Molecular profiling of over 1,000 nasopharyngeal cancer (NPC) tumours reveals distinct differences in tumour microenvironment of locoregionally advanced NPC, supporting personalised treatment.

A new PET imaging technique can accurately detect and monitor Mycobacteroides abscessus lung infections—one of the most difficult-to-diagnose conditions in patients with lung diseases.

A research team at the University of Geneva has identified two new proteins that regulate gene expression, a discovery that could pave the way for new cancer and brain disorder treatments.

New research makes a strong case for a new dual-targeting radiopharmaceutical, designed to attach to two vulnerable sites on cancer cells, enabling more precise and potent therapy.

The use of surgical robots offers a wide range of possibilities, but in Europe the technology is often unable to reach its full potential. Dr. med. Christoph Wandhöfer explains why.

Using nine different molecular biological technologies, researchers were able to precisely measure the properties of a melanoma tumor in four weeks and enable a precise treatment decision.

Lung cancer is the leading cause of cancer death in the EU, yet no organized screening program exists to detect the disease before symptoms appear. This September, France will strike back with an ambitious pilot program that could boost European lung cancer screening. Professor Marie-Pierre Revel presented the details at the French Thoracic Imaging Society Spring Days in Marseille, highlighting…

United Imaging, a global leader in cutting-edge diagnostic imaging and radiotherapy solutions, proudly unveils two groundbreaking additions to its portfolio — the uMI Panvivo and the uMR Ultra — both newly CE-marked and set to redefine the standards of precision and performance in medical imaging.

Tongue squamous cell carcinoma, the most common type of oral cancer, is a challenging target for immunotherapies. Researchers now identified five immunotypes to better predict treatment response.

Newborns, especially those born prematurely, are vulnerable to conditions such as sepsis. A new device profiles an infant’s immune function from a single drop of blood to improve neonatal care.

When it comes to breast cancer, ethnic differences matter, putting some women at a significantly higher risk, a new study finds. Genetic ancestry should therefore be considered as a risk factor.

Results of a new retrospective study demonstrate the potential of a novel, CT-based deep learning-driven tool to enhance liver cancer diagnosis, treatment planning, and response evaluation.

A new approach enables the detection of even trace amounts of cancer cells. The method leverages SERS for signal amplification, eliminating the need for fluorescent dyes.

Bringing diagnostics and therapy closer together - that is the basic concept behind theranostics. Through further development of its PET/MR scanners, Siemens Healthineers aims to advance this approach. Andreas Schneck, Head of the MRI Division at Siemens Healthineers, talks about the new system, which was also presented at the European Congress of Radiology (ECR) in Vienna, and its advantages in…

Unprecedented insights into the inner workings of an early-stage lung tumor: An international research team describes a new method for 3D mapping cellular interactions in the tumor microenvironment.

Dr Ari Melnick has been appointed the new Director of the Josep Carreras Leukaemia Research Institute by the Board of Trustees. The institute specialises in biomedical research and precision medicine in the field of leukaemia and other hematologic malignancies.

Breast MRI has emerged as a powerful diagnostic tool, particularly for women with dense breast tissue where traditional mammography faces limitations. In her presentation at ECR 2025, radiographer Hanna Kalliomäki highlighted several technological advances transforming breast cancer detection and diagnosis. From time-saving abbreviated protocols and AI-assisted analysis to contrast-free…

Nuclear medicine (NM), one of the more mature technologies of diagnostic imaging, has been experiencing a rebirth in innovation and interest. The increasing prevalence of cancer,, an aging global population, and greater longevity, has created a robust demand for nuclear medicine. At ECR in Vienna, presenters explored market perspectives, but also safety and sustainability challenges.

Radiation safety experts developed a multi-purpose detector with a wide range of tools for different uses into a small package. For example, the detector detects all four kinds of ionizing radiation.

A new, simpler and cheaper analytical method for the early detection of Alzheimer's disease could help bring blood tests into the healthcare system globally, according to a new study.

The new national Precision Omics Initiative Sweden (PROMISE) aims to generate and integrate extensive molecular data to create a model for precision medicine implementation for Sweden.

An international research team has developed an intelligent device capable of monitoring the skin continuously and accurately detect temperature variations associated with inflammation and infection.

China Import and Export Fair, also known as the “Canton Fair”, is the World’s No.1 Expo in terms of scale. Canton Fair will see its 137th session to be held from April 15 to May 5, 2025 in Guangzhou, China. The Health & Medicine Sector of 137th Canton Fair, to be staged from May 1-May 5, will have 1000+ exhibitors with thousands of new products.

Smaller than a grain of rice: US engineers have developed a pacemaker so tiny that it can fit inside the tip of a syringe — and be non-invasively injected into the body.

Using the COX-2 enzyme, a new PET imaging approach offers a never-before-seen view of inflammation in the brain, opening the door for clinical and research settings for various brain disorders.

Leveraging bioink from pancreatic tissue and 3D bioprinting, researchers developed a structure closely mimicking the structure of a pancreas, in which cultured cells can resume insulin production.

Nuclear medicine specialists have successfully used the radiopharmaceutical Ga-68-Trivehexin from Trimt to accurately diagnose patients with pulmonary fibrosis and concurrent lung cancer.

A greater emphasis on AI and sustainability, new approaches to mitigating staff shortage and more: At the European Congress of Radiology (ECR) 2025 in Vienna, Philips showcased its approaches to several critical issues in diagnostic imaging. The global healthtech company presented solutions addressing today's healthcare challenges while aligning with the congress's "Planet…

Agios Andreas General Hospital of Patras, Greece, is set to enhance its diagnostic capabilities with the installation of a new digital PET/CT imaging system.

Giving separated blood plasma improves outcomes in patients with traumatic brain injury (TBI) or shock, whereas unseparated or “whole” blood may be best for patients with traumatic bleeding.

A new PET tracer has the potential to play a critical role in the diagnosis, treatment, and monitoring of aggressive triple-negative breast cancer (TNBC), improving clinical outcomes for patients.

Blood-based biomarker (BBB) tests may represent the best weapon to combat the soaring rates of Alzheimer’s disease (AD) throughout the world. Existing clinically validated tests are currently deployed to facilitate diagnosis, to monitor disease and effectiveness of treatments, to quantify progression, and to determine if a patient is appropriate for treatment or participation in a clinical…

Anatomically accurate 3D-printed phantoms for CT imaging and AI training show promise as an alternative to cadavers. The new technology allows for patient-specific phantoms with realistic radiopacity.

By detecting nerve connections in the injured spinal cord, a newly developed radiotracer could help diagnose injuries more precisely, monitor recovery, and evaluate therapy effectiveness.

Research on biliary tract cancer is advancing rapidly, ranging from targeted treatments to new drugs. However, the delivery of these advances to patients is lagging behind, new European studies find.

New research highlights the potential of circulating tumor DNA (ctDNA) analysis as a non-invasive method to identify actionable biomarkers for breast cancer, enabling individualized therapies.

Promising insights into amyotrophic lateral sclerosis (ALS): New research links characteristic symptoms of the disease, such as motor impairment and respiratory issues, to sleep disorders.

Molecular changes associated with brain inflammation and dementia can be detected in the blood. Researchers want to use this to establish blood tests as an alternative to more costly brain scans.

The Diagnostica e Terapia Centro Aktis in Marano di Napoli, Italy, has expanded its diagnostic department with the addition of three imaging systems from United Imaging.

When multiple myeloma cancer cells break out and multiply outside the bone marrow, a wide variety of tumor cells arise, accompanied by a significantly altered immune response, new research shows.

Certain gene alterations can serve as a prognostic and predictive biomarker for prostate cancer. Now, researchers confirm the feasibility of using NGS on this marker for precise patient stratification and treatment selection.

Using 3D imaging and deep learning AI, researchers have developed a new way to accurately assess body fat and muscle distribution, which are crucial for understanding health risks.

A sensor, similar to glucose monitoring devices, detects lung cancer biomarkers from a blood sample in just 40 minutes. The technology has potential to identify at-risk patients and tailor treatments.

Patient safety is at the heart of every medical advancement, and technologies like endoscopes have been pivotal in transforming surgery by enabling minimally invasive procedures. This evolution has led to safer operations, reduced complications, and improved patient outcomes. However, these advancements depend on rigorous hygiene protocols for reusable medical equipment.

Helping the brain repair itself after a stroke: A new study based on unique tissue samples from Denmark's Brain Bank may pave the way for new treatments that support brain regeneration.

Senescent cells, which may appear after chemotherapy or radiotherapy, can jeopardize patients' recovery. A study describes a new mechanism to eliminate these cells in cancer patients.

The immune system of children reacts differently to cancer than that of adults. New insights into these differences have the potential to lead to new tailored treatments for children with cancer.

The installation of a state-of-the-art digital PET/CT scanner in Essen marks the German debut for the technology of United Imaging. The device is designed to deliver precision diagnostics at the Kliniken Essen-Mitte Evang and the private nuclear medicine clinic Nukmed, a premier cancer care institution.

Better protection against cybercrime, more efficient threat deterrence: The European Commission has presented an EU action plan to bolster the cybersecurity of hospitals and healthcare providers.

The vaccine to protect against Hepatitis E is given in a 3-dose regimen. However, in an epidemic setting, two doses have also proven effective, a new study shows.

A new personalised oncology platform has been tested to detect circulating tumour DNA (ctDNA) in patients with lung adenocarcinoma before surgery, to predict their risk of cancer relapse.

Researchers at the National University of Singapore (NUS) have developed a non-invasive method to improve the effectiveness of breast cancer chemotherapy while reducing its harmful side effects.

Complex diseases could require complex biomarkers for accurate diagnosis in the years ahead, according to a leading pathologist. In a keynote address to the 36th European Congress of Pathology in Florence, Italy, Professor Manuel Salto-Tellez highlighted this as one of the major future challenges for the discipline. However, he also believes pathologists will sit at the core of modern medicine.

Research offers new insights into harnessing the immune system to combat ovarian cancer. The findings could lead to personalized therapies that target the right patients at the right time.

Metabolic-associated fatty liver disease has 2 types – a liver-specific type and a systemic type that affects other organs and tissues. This discovery could lead to better diagnosis and treatments.

Experts have used magnetic resonance imaging (MRI) to better understand the impact a gluten free diet has on people with celiac disease, which could be the first step towards new treatments.

Precise segmentation of anatomical structures greatly benefits cancer diagnosis. Using AI and deep learning methods, researchers are developing a high-precision 3D viewer software for medical image data.

To advance the transition of AI from research to clinical application, Nvidia announced that Siemens Healthineers has adopted MONAI, an open-source medical imaging framework.

The current rise in antibiotic resistance is once again sparking interest in phage therapy. Now, scientists developed a new tool that recommends the best possible phage cocktail for a given patient.

A research team has found wearable organic x-ray sensors could be the answer towards safer radiotherapy protocols for cancer patients, reducing the debilitating side-effects of the treatment.

United Imaging are excited to share that, in partnership with Fora S.p.A., an industry leader with over 50 years of expertise in delivering advanced diagnostic technologies to the Italian market, Policlinico Casilino Hospital will join the company's global network. Demonstrating its commitment to innovation and growth, the hospital has selected the industry-leading 640-slice CT scanner to…

Future-oriented large-scale investments on the one hand, political unrest on the other: The presentation of award-winning medical technology from Taiwan at Medica in Düsseldorf reflected a year full of changes and challenges. The prize-winning solutions for surgery, intensive care medicine, traumatology and endoscopy once again attracted a large professional audience.

When an AI advisor points out an area of concern in a chest X-ray, radiologists are sometimes all too eager to follow their lead, a new study finds. This may lead to incorrect diagnostic decisions.

Researchers have published findings that show the genetic structure of the heart’s shape may offer new insights into individual heart health.

How can innovations help to master challenges and demands in healthcare? This central question will be addressed at the Medica Health IT Forum, an established part of the programme at the trade fair.

Multiplex imaging can play a critical role in unravelling the tumour microenvironment. The potential and benefits of the emerging approach – a way to extract information from human tissue samples by visualising many more biomarkers than traditional microscopy – was highlighted in presentations during the 36th European Congress of Pathology in Florence, Italy. Speakers also discussed novel…

New research suggests that transcranial ultrasound stimulation (TUS) could be used to help people with pain, alcoholism, OCD, and Parkinson’s disease, without drugs or surgery.

Misfolded proteins lead to Alzheimer's disease – but where do they come from? Using a particularly powerful imaging technique, Swiss researchers now uncovered a key mechanism.

Increasing implementation of robotic automation and AI will speed up scientific progress in science laboratories, according to a new study. The experts outline this process across distinctive levels.

United Imaging launches the uMI Panvivo, the uMI Panorama GS and Nuclear Medicine AI Solution at EANM, and announces strategic partnerships, reinforcing its commitment to advancing molecular imaging in Europe and beyond.

Insulinomas are benign tumors in the pancreas, but can still cause problems for patients. A new imaging technique reliably detects these previously hard-to-find tumors, according to recent research.

Taipei City is set to make a splash at the Medica 2024 trade fair. The city's Department of Economic Development has curated an exhibition area, featuring six innovative biotech companies.

Immunotherapy has become the most promising strategy for treating several cancers, but its effectiveness is still very uneven. Three researchers explain how research is being done to change this.

A European research team has now shown that dietary measures are more effective in IBS patients with defects in carbohydrate digestion genes than in those without these changes.

Minimally invasive surgical interventions, innovative imaging and the use of AI: At the upcoming EUSOBI congress in Lisbon, experts present and discuss the latest advances in breast imaging. We spoke with Tanja Brycker from Hologic ahead of the event about new trends in women’s health, the company’s investment in innovation and education, and what the future of mammography looks like with the…

Using smartly trained neural networks, researchers at TU Graz have succeeded in generating precise real-time images of the beating heart from just a few MRI measurement data.

A bit more mucus in the nose, a little less air in the gut: Even small changes can be important when planning proton therapy against cancer. A new workflow allows for an adapted irradiation every day.

Researchers have identified biomarkers that, in conjunction with PET imaging, enable doctors to reliably distinguish between primary 4-repeat tauopathies and Alzheimer's disease.

A new type of magnetically controlled prosthetic hand allows amputees to reproduce all movements simply by thinking and to control the force applied when grasping fragile objects.

Brain aneurysms cause around 500,000 deaths globally each year and can lead to stroke and disability. Now, researchers created nanoscale robots to manage bleeds in the brain caused by aneurysms.

A US-Swiss team leverages AI and molecular simulations to uncover new pathways for precision cancer treatments, paving the way for more effective, personalized therapies.

A new method of analysing the crystals in dehydrated blood could lead to a quicker, cheaper and less painful technique to diagnose, early detect, and monitor prostate cancer.

Researchers have developed an artificial intelligence which can differentiate cancer cells from normal cells, as well as detect the very early stages of viral infection inside cells.

To diagnose neuroblastoma in children, lengthy scans and anaesthesia are often required. A new PET/CT imaging technique could deliver faster results without sedation for the paediatric patients.

United Imaging, a company specializing in advanced imaging solutions, is proud to announce the first installment of their cutting-edge technology in France. The increasing number of healthcare facilities deciding to leverage the company's diagnostic solutions stands as a testament to their effort toward engineering imaging solutions that hold the potential to transform patients’ lives worldwide.

Can a look at a patient's DNA predict progress of their colorectal cancer? Findings from a new study could lead to improved possibilities for individualised therapies.

A new type of contrast agent for use in both MRI and PET imaging has the potential to significantly enhance diagnosis and subsequent treatment, particularly for kidney diseases and tumors.

Metastases, but no sign of the original tumor: A large international study shows how this phantom cancer can nevertheless be treated.

The pace of artificial intelligence (AI) adoption in personalised medicine is unsettling for great parts of the public. A new survey reflects the worried state of mind in the UK.

Cancer, dementia, heart attack: these are the medical conditions people are most worried about, according to a new UK survey. It also reveals hopes for AI in the future of cancer research and care.

Sentinel lymph node biopsies can help detect breast cancer – but not every patient benefits from the procedure. New research finds that a simple EHR prompt can prevent unnecessary surgery.

Using genomic sequencing data, researchers have created personalised simulations of individual patients that can quantify the impact of genetic mutations on cancer cell behaviour.

Using advanced technology from the automotive and manufacturing industries, researchers are driving medical advancement to create ‘personalised’ hip replacements.

New research shows that the AI large language model ChatGPT can be tailored to provide accurate responses to questions about digital pathology and compile detailed results.

As demand for innovative healthcare solutions is at an all-time high, Medical Taiwan once again attracted a record number of visitors for its 2024 edition. The show’s organizer, the Taiwan External Trade Development Council (TAITRA), proudly reported an increase in attendance by 10% compared with the previous year. During the three-day event in Taipei, the audience was treated to a wide range…

When colorectal surgery was first performed with robotic assistance in 2014, the procedure was questioned about safety, efficacy, and outcomes. Today it is an established option. Well-trained surgeons use robotic surgical systems confidently. Numerous clinical studies have verified its intraoperative benefits for patients and surgeons alike, as well as very positive outcomes for patients.

The new Nuclear Medicine Department of the San Pietro Fatebenefratelli Hospital was inaugurated in Rome. The Department was inaugurated with the online intervention of Health Minister Orazio Schillaci and in the presence of Maria Tripodi (Undersecretary at the Ministry of Foreign Affairs and International Cooperation), Antonello Aurigemma (President of Lazio Regional Council).

Using specific radiomics features from 70 characteristics in MRI images, researchers develop an objective method to predict the hearing status of patients with vestibular schwannoma.

Researchers have developed a technology for targeted stimulation of the brain with ultrasound. This could be used to treat diseases and conditions such as epilepsy, Parkinson’s disease, depression, addiction, and even the aftereffects of stroke.

Surgeons in Hong Kong have successfully introduced robotic assistance into their spinal surgery portfolio. After the first 20 procedures with the new technique, they report on the benefits.

The IRCCS in Bologna has inaugurated a state-of-the-art integrated PET/CT system. This cutting-edge technology allows for the entire human body to be studied in a single scan, even detecting the smallest tumour cells.

Digital twin technology can transform clinical practice by aiding patient-specific prediction and supporting personalized treatment models. Expert speakers at an ECR 2024 session in Vienna focussed on how radiology will play a leading role in the advance through data acquisition via a range of imaging modalities.

Acute myeloid leukaemia (AML) is a common type of blood cancer in childhood and can be diagnosed within a few months of life. New research shows that its origins can be traced back to before birth.

A new interdisciplinary research group explores issues of explainability and comprehensibility of AI in medicine – and who is responsible when something goes wrong.

Due to climate change, diseases such as West Nile fever reach European countries. With the help of AI and math, institutions can prepare for new infections in the changing climate, new research shows.

Medical imaging and radiotherapy equipment company United Imaging are delighted to extend a warm welcome to Cobellis Clinic, the latest treatment centre to join their global family of clients. With an unwavering commitment to providing the highest level of healthcare services, the clinic has made a strategic decision to rely on the manufacturer's state-of-the-art imaging technology.

A United Imaging Healthcare uCT 780 CT scanner has been installed at the Ospedale di Circolo e Fondazione Macchi di Varese in the small town of Varese in the far north-western province of Lombardy.

Researchers have developed a cutting-edge method for fabrication of customised pharmaceutical tablets with tailored drug release profiles, ensuring more precise and effective treatment options.

A new SPECT/CT imaging technique using lead-212 (²¹²Pb) shows promise in targeted alpha therapy (TAT) for patients with metastatic castration-resistant prostate cancer.

Experts at Newcastle University have discovered artificial intelligence can be used to analyse medical imaging from CT scans, which is aimed at predicting survival in patients with laryngeal cancer.

Researchers discovered three distinct immunological endophenotypes of multiple sclerosis, defined by specific blood immune signatures. This opens new avenues for personalized treatment strategies.

Researchers are developing novel active substances designed to cut off the nutrient supply of resistant bacteria, effectively starving them to death.

Using 3D bioprinting to accurately replicate the biological environment surrounding gastric cancer cells, researchers predicted a patient’s response to anticancer drugs during the preclinical stage.

A team of Northwestern University scientists has developed the first wireless, implantable temperature sensor to detect inflammatory flareups in patients with Crohn’s disease.

Multiplex PET imaging technology could provide a ground-breaking new approach for diagnosing and treating bowel cancer patients, according to scientists in Glasgow.

Radiologists and AI don’t always work well together: New research finds that the benefits of using AI tools appear to vary, boosting performance of some clinicians, but hurting others'.

A novel AI-based, non-invasive diagnostic tool enables accurate brain tumor diagnosis, outperforming current classification methods. The tool leverages MRI information to aid clinical decision making.

Researchers work on the first prototype that applies AI to colorectal diagnosis. The prototype achieved a diagnostic acuity of 93.44% and a sensitivity of 99.7% in the detection of high-risk lesions.

Striking the balance between diagnostic efficacy and patient safety remains critical when utilising iodinated contrast media to deliver the best imaging outcomes. While playing a crucial role in diagnosis and treatment of disease, CT expert Efthimios Agadakos believes the medical profession has a duty to do its utmost to minimize patient risk from contrast media.

In a breakthrough for personalised oncology, scientists have developed and demonstrated a novel platform that can significantly reduce the time needed to determine the efficacy of anti-cancer drugs.

A team of researchers has discovered a new method of measuring levels of cortisol directly from a blood sample - a significant step forward in diagnosis and treatment of a wide range of diseases.

‘Next Generation Radiology: Embracing the future and redefining the field of radiology’: In the run-up to the European Congress of Radiology 2024, we spoke with ESR President Professor Carlo Catalano from Rome, Italy, about the meeting’s content and its intriguing theme.

GE HealthCare and the European Society of Radiology (ESR) renew their collaboration for the upcoming European Congress of Radiology (ECR) from February 28 to March 3 in Vienna.

Researchers have developed a 3D-bioprinted, miniaturized chip to advance the understanding of cardiovascular disease and aid in the development of new precision treatments.

Juggling the cost of quality control (QC) resources versus the risk of testing error is a balancing act no clinical laboratory manager enjoys. It is an inexact process, itself prone to error, which can impact the operations of hospital labs and independent clinical testing companies. In the current resource-constrained healthcare environment, there is pressure to improve the cost effectiveness of…

Chemotherapy can be toxic to heart cells. To help protect the hearts of cancer patients, Cedars-Sinai investigators have created a three-dimensional “heart-on-a-chip” to evaluate drug safety.

AI technology holds promise for personalised cancer therapies. However, rigid and slow approval requirements impede its introduction, say experts – and point out how this might be changed.

United Imaging Healthcare Europe, a leading company in advanced medical imaging and radiotherapy equipment, proudly announces the introduction of its first Mobile Digital PET/CT solution in Italy, now fully operational in the Piacenza province under the auspices of the Azienda Unità Sanitaria Locale Piacenza (AUSLP) hospital.

Three disease subtypes, based on causes rather than symptoms: A new classification model for Parkinson's disease aims to pave the way for better diagnostics and therapies.

A new soldering technique developed by Empa researchers is expected to prevent wound healing disorders and life-threatening complications from leaking sutures.

Certain genetic features are crucial for treatment decisions for AML leukaemia. A team from Münster shows how an AI-based method can predict these features from images of bone marrow smears.

Contraception, wound healing, arthritis treatment: Here are three recent papers published in ACS journals that could expand the beneficial uses for nanoparticles, based on results in rats.

A research team from Denmark has developed an innovative screening test. With a blood sample from the expectant mother, they can scrutinize all the genes in the fetus.

Operating a surgical robot is complicated, but now, researchers may have found a surprising way to shorten the learning process: with electricity applied to the head.

While genetic information may lead to better treatments, promises of cost savings are unfounded. Instead, a large additional bill is more likely, according to University of Copenhagen researchers.

US researchers discuss three blood-based liquid biopsies, namely circulating tumor cells, circulating tumor DNA and tumor-derived exosomes, as they relate to prostate cancer management.

Scientists map the effects of 86 immune-signaling molecules called cytokines on every major immune cell type, creating a reference for studying the inner workings of the immune system.

Researchers from the University of Birmingham have designed and developed a novel diagnostic device to detect traumatic brain injury (TBI) by shining a safe laser into the eye.

A new deep-learning approach to AMR testing has been shown to detect antimicrobial susceptibility within as little as 30 minutes - significantly faster than current gold-standard approaches.

The world's leading medical trade fair MEDICA 2023 starts on Monday in Düsseldorf with more than 5,300 exhibiting companies from almost 70 nations and the kick-off event for the accompanying 46th German Hospital Day, which will be attended by Federal Health Minister Karl Lauterbach (via video link) and NRW Health Minister Karl-Josef Laumann. COMPAMED 2023 will take place parallel to MEDICA. As…

Ultrasound technology now plays a vital role in clinical diagnosis and management. Significant advances in point-of-care ultrasound (POCUS) have made it a versatile tool for assessment, diagnosis, and follow-up across various fields. New developments continue to expand its applications, improving patient care and outcomes.

Sure, AI still has a long way go. But maybe one day in the not-so-distant future, AI will provide us with information about our current state of health, such as the number of red blood cells, cholesterol levels, fat percentage, and how many seconds last night's beer will shorten our life expectancy.

A mechanism that led some patients to experience cases of deadly clotting following some types of Covid-19 vaccination has been identified in new research.

Chemotherapy, radiotherapy or surgery – these are the three common forms of cancer therapy. Now, lymphoma specialists in Essen are investigating the possibility of a different approach.

High-BMI patients are a challenge for abdominal sonography. In a new study, researchers point out the benefits of special high-performance probes and their impact on image quality.

What role should artificial life play in medicine? Researchers from Denmark and the US explore the potential of hybrid peptide-DNA nanostructures for diagnosing and treating diseases.

A team at the University of Bristol has developed a robot manipulator that could carry out clinical breast examinations. The developers hope the device will revolutionise breast health monitoring.

Two out of the four screening tools used by emergency medical services are inadequate for recognising sepsis, according to new research presented at the EUSEM Congress.

A new type of microdevice could offer new ways to treat brain cancer. The shape and size of a grain of rice, it is implanted into a tumor to study the effects of ongoing therapies.

It had long been recognized that the brain was made up of two types of cells, neurons and glial cells. Now, neuroscientists discovered an additional type - with huge implications for brain disorders.

Researchers have developed an aero-elastic pressure sensor to provide increased precision and reliability across medical applications, such as minimally-invasive surgeries and implantable sensors.

A new analysis exploring the finances of bringing new cancer drugs to market has found that precision oncology drugs could be $1 billion cheaper to develop than non-precision drugs.

A team from Geneva demonstrates the value of imaging to detect the presence of tau protein in the brain to predict cognitive decline due to Alzheimer’s disease.

To reduce avoidable errors, especially involving injectable medications in anaesthesia care, UK experts have published a new guidance on safe injection practice.

Experts have highlighted how precision pathology using Artificial Intelligence can provide an effective alternative to molecular diagnostics. This, say a team from the Karolinska Institutet (KI) in Stockholm, Sweden, can also offer multiple advantages within a clinical setting and support risk stratification.

Scientists have developed a tool to create a digital replica of an individual's heart, which could inform the diagnosis and treatment of cardiovascular diseases.

University of Ottawa scientists have introduced a metal-free MRI dye capable of mapping kidney function with unprecedented accuracy — a promising technique for more personalized care.

By using genetic data on multiple traits from people of non-European ancestry, scientists have improved the accuracy of polygenic scores in predicting disease risk for all.

What will the future structure for artificial intelligence in health imaging across Europe look like? While the algorithms show great promise in collecting, storing, analysing, and using data to advance healthcare, delegates to a session on the topic at ECR 2023 in Vienna, also heard that it was important for the use of AI to move from research and more toward practical applications for patients.…

More than half a billion people are living with diabetes worldwide, and that number is projected to more than double to 1.3 billion people in the next 30 years.

US researchers evaluated AI techniques for cleaning medical images based on performance in clinical tasks. Some algorithms make the scans look better, but actually decrease image quality.

Genomic sequencing panels as part of personalised cancer treatment have been found to only benefit one in 20 patients they are currently used for, according to a study by CNIO.

Today, a large part of all further medical treatments is based on the results of laboratory analyses. The demand for complex test procedures remains high and the challenges for laboratories are growing.

Unanswered questions are hampering clinicians in their efforts to get the best out of a precision medicine approach for their patients. Speaking at the Genomics and Precision Medicine Expo in London at the end of May, cancer educator Dr Elaine Vickers said the benefits of being matched to an investigational drug remain questionable for most people with advanced cancer.